Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Boston Scientific Corporation (BSX:NYSE), powered by AI.
Boston Scientific Corporation is currently trading at $46.91. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Boston Scientific Corporation on Alpha Lenz.
Boston Scientific Corporation's P/E ratio is 24.0.
“Boston Scientific Corporation trades at a P/E of 24.0 (fair value) with solid ROE of 12.6%. 3Y revenue CAGR of 16.5% highlights clear growth momentum.”
Ask for details →Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.
“Boston Scientific Corporation trades at a P/E of 24.0 (fair value) with solid ROE of 12.6%. 3Y revenue CAGR of 16.5% highlights clear growth momentum.”
Ask for details →Boston Scientific Corporation (ticker: BSX) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 53,000 employees. Market cap is $69.4B.
The current price is $46.91 with a P/E ratio of 23.96x and P/B of 2.87x.
ROE is 12.60% and operating margin is 19.78%. Annual revenue is $20.1B.